ipamorelin increases igf-1 does increase igf 1 ipamorelin clinical study growth hormone release safety 5 Powerful Benefits (and Risks) of the LR3 and Hexarelin IPA/CJC/IGF BLEND - Beverly Hills

N Engl J Med 370 , 20832092

Development of a cyst-targeted therapy for polycystic kidney disease using an antagonistic dimeric IgA monoclonal antibody against cMET

Abbreviations CKD: Chronic kidney disease CT: Computed tomography eGFR: Estimated glomerular filtration rate HD: Hemodialysis HIRA: Health Insurance Review and Assessment ICD-10: International Classification of Diseases 10th Revision IPF: Idiopathic pulmonary fibrosis KT: Kidney transplantation NHIS: National Health Insurance System PD: Peritoneal dialysis PDGF: Platelet-derived growth factor RRT: Renal replacement therapy References Raghu, G

Taken together, the current available data suggest that GH and/or IGF-1 regulate acid-base hemostasis by stimulation of ammonia production in the proximal renal tubule and/or by a Na-dependent mechanism in the collecting duct, resulting in enhanced proton secretion

This produces sustained GH elevation rather than the pulsatile release that ipamorelin creates

Ipamorelin is an off-label, non-FDA-approved peptide used for wellness purposes